|Bid||0.00 x 4000|
|Ask||6.99 x 2200|
|Day's Range||5.31 - 5.49|
|52 Week Range||4.78 - 7.79|
|Beta (3Y Monthly)||2.07|
|PE Ratio (TTM)||213.20|
|Earnings Date||Nov 6, 2018 - Nov 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||13.50|
NEW YORK, Oct. 11, 2018 -- HC2 Holdings, Inc. (“HC2”) (NYSE: HCHC), a diversified holding company, announced today that its operating subsidiary DBM Global Inc. (“DBM Global”).
HC2 Holdings, Inc. (“HC2”) (HCHC), a diversified holding company, announced today that its broadcasting subsidiary, HC2 Broadcasting Holdings Inc. (“HC2 Broadcasting”), has established a strategic distribution partnership with The Christian Broadcasting Network (“CBN”) for its launch of The CBN News Channel, the first 24-hour Christian television news channel. Under the new distribution agreement, HC2 Broadcasting will initially broadcast the new CBN News Channel in 13 of HC2 Broadcasting’s 134 markets across the United States, including Los Angeles, Atlanta, Detroit and St. Louis. The distribution partnership provides CBN the ability to expand distribution to other markets across the country through HC2 Broadcasting’s nationwide, ‘yet to be branded’, over-the-air (“OTA”) network.
Investors need to pay close attention to HC2 Holdings (HCHC) stock based on the movements in the options market lately.
Every investor in HC2 Holdings Inc (NYSE:HCHC) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders oftenRead More...
HC2 Holdings, Inc. (“HC2”) (HCHC), a diversified holding company, announced today that the parent company of its telecom subsidiary PTGi-ICS has changed its name from Arbinet Corporation to ICS Group Holdings Inc., (“ICS Group”). ICS Group’s mandate is to seek out and purchase companies that have a proven track record, a strong balance sheet and low capital expenditures. Target acquisitions will be small to medium opportunities in the communication and Information Technology (“IT”) marketplace globally. HC2 also announced that ICS Group has entered into a definitive agreement to acquire Go2Tel.com Inc. (“Go2Tel”), a well-established VoIP carrier that offers high-quality termination services, primarily in Latin America, South America and the Caribbean. Based in Miami, FL, Go2Tel also has a skilled team with presence in Colombia, Bolivia and Spain, and alliances with more than 200 companies in their region.
NEW YORK, Aug. 09, 2018-- HC2 Holdings, Inc., a diversified holding company, announced today that its insurance subsidiary, Continental General Insurance Company, has completed its acquisition of the long-term ...
HC2 Holdings (HCHC) delivered earnings and revenue surprises of -53.33% and 9.37%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
The New York-based company said it had profit of $1.08 per share. Losses, adjusted for non-recurring gains, were 69 cents per share. The diversified holding company posted revenue of $496.8 million in ...
Re-Affirms 2018 Guidance for Construction and Marine Services Segments. NEW YORK, Aug. 08, 2018-- HC2 Holdings, Inc., a diversified holding company, announced today its consolidated results for the second ...
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / HC2 Holdings, Inc. (NYSE: HCHC ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 5:00 PM Eastern Time. To ...
Phil Falcone, HC2 Holdings Inc. chairman and chief executive officer, discusses the company's investments in biotech, broadcast and Vietnam with Bloomberg's Betty Liu on "What'd You Miss?" (Source: ...
The New York-based company said it had a loss of 81 cents per share. The diversified holding company posted revenue of $453.7 million in the period. HC2 Holdings shares have climbed roughly 7 percent since ...
Moody's Investors Service ("Moody's") commented on HC2 Holdings, Inc's. announcement that its Pansend Life Sciences subsidiary has agreed to sell BeneVir Biopharm, Inc. to Janssen Biotech, Inc. for an upfront cash payment of $140 million plus additional contingent payments of up to $900 million based on the achievement of certain predetermined milestones. For any credit ratings referenced in this publication, please see the ratings tab on the issuer/entity page on www.moodys.com for the most updated credit rating action information and rating history.